| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.708 | 3.687 |
| Total Income - EUR | 243 | 397 | 390 | 194 | 105 | 53 | 40 | 386 | 3.961 | 3.721 |
| Total Expenses - EUR | 1.028 | 1.037 | 2.781 | 430 | 696 | 557 | 277 | 384 | 2.053 | 1.241 |
| Gross Profit/Loss - EUR | -785 | -640 | -2.391 | -236 | -591 | -503 | -238 | 2 | 1.908 | 2.480 |
| Net Profit/Loss - EUR | -785 | -640 | -2.391 | -236 | -591 | -503 | -238 | 2 | 1.603 | 2.083 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Euromed Investments Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 18.945 | 18.751 | 18.434 | 18.096 | 17.745 | 17.409 | 17.023 | 17.076 | 17.024 | 20.616 |
| Inventories | 15.819 | 15.658 | 15.393 | 15.111 | 14.818 | 14.537 | 14.215 | 14.259 | 14.216 | 14.136 |
| Receivables | 3.125 | 3.093 | 3.041 | 2.985 | 2.927 | 2.872 | 2.808 | 2.817 | 2.809 | 6.480 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | -12.922 | -13.430 | -15.594 | -15.543 | -15.833 | -16.036 | -15.918 | -15.965 | -14.314 | -12.151 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 31.866 | 32.181 | 34.028 | 33.639 | 33.578 | 33.445 | 32.941 | 33.041 | 31.338 | 32.767 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6810 - 6810" | |||||||||
| CAEN Financial Year |
6810
|
|||||||||
Comments - Euromed Investments Srl